Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Genzyme’s once-daily, oral AUBAGIO® (teriflunomide) approved in Argentina for the treatment of relapsing multiple sclerosis
A monoclonal natural human IgM protects axons in the absence of remyelination.
12-oxo-phytodienoic acid, a plant-derived oxylipin, attenuates lipopolysaccharide-induced inflammation in microglia.
Biogen slips as FDA extends review of MS drug
Clinically isolated syndromes: a new oligoclonal band test accurately predicts conversion to MS.
Ncx3 gene ablation impairs oligodendrocyte precursor response and increases susceptibility to experimental autoimmune encephalomyelitis.
Eosinophilic Fasciitis-like Disorder Developing in the Setting of Multiple Sclerosis Therapy.
Mitoxantrone induces natural killer cell maturation in patients with secondary progressive multiple sclerosis.
The effects of diet on the severity of central nervous system disease: One part of lab-to-lab variability.
Diplomatic Assistance: Can Helminth-Modulated Macrophages Act as Treatment for Inflammatory Disease?
European/Canadian multicenter, double-blind, randomized, placebo-controlled study of the effects of glatiramer acetate on magnetic resonance imaging--measured disease activity and burden in patients with relapsing multiple sclerosis.
Susceptibility tensor imaging (STI) of the brain.
Neuron-specific SALM5 limits inflammation in the CNS via its interaction with HVEM.
Management of multiple sclerosis and the integration of related specialty pharmacy programs within health systems.
Oligodendrogliopathy in Multiple Sclerosis: Low Glycolytic Metabolic Rate Promotes Oligodendrocyte Survival.
Interferon β-secreting mesenchymal stem cells combined with minocycline attenuate experimental autoimmune encephalomyelitis.
Mitoxantrone in progressive multiple sclerosis: a placebo-controlled, double-blind, randomised, multicentre trial.
Brain-gut axis and pentadecapeptide BPC 157. Theoretical and practical implications.
Compromised axon initial segment integrity in EAE is preceded by microglial reactivity and contact.
Tract-specific and age-related variations of the spinal cord microstructure: a multi-parametric MRI study using diffusion tensor imaging (DTI) and inhomogeneous magnetization transfer (ihMT).
Teriflunomide attenuates immunopathological changes in the dark agouti rat model of experimental autoimmune encephalomyelitis.
Safety and efficacy of the selective sphingosine 1-phosphate receptor modulator ozanimod in relapsing multiple sclerosis (RADIANCE): a randomised, placebo-controlled, phase 2 trial.
Magnetic resonance imaging of myelin using ultrashort Echo time (UTE) pulse sequences: Phantom, specimen, volunteer and multiple sclerosis patient studies.
Arginase-1 is expressed exclusively by infiltrating myeloid cells in CNS injury and disease.
A novel adaptive design strategy increases the efficiency of clinical trials in secondary progressive multiple sclerosis.

Pages